Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00730678 · ClinicalTrials.gov registry record

Pharmacogenetic Determinants Of Treatment Response In Children

A clinical trial of All Malignancies and Children Being Treated for Catastrophic Illness, sponsored by St. Jude Children's Research Hospital.

Recruiting
Registry status
8,800
Enrollment target
1
Study location

NCT00730678 is a study of All Malignancies and Children Being Treated for Catastrophic Illness that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 8,800 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00730678, a study of All Malignancies and Children Being Treated for Catastrophic Illness, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.

RECRUITING
Registry status
8,800 participants
Enrollment target
1
Study location

Study Summary

To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the disposition or effects of these xenobiotic substrates. To investigate the nature of heritability and the genetic basis of pharmacogenetic traits by studying family members of individuals with specific genotypes.

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 8,800 participants
Start Date 1998-08-17
Est. Completion 2034-03

What the Registry Record Tells You About NCT00730678

The ClinicalTrials.gov registry entry for NCT00730678 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 8,800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with All Malignancies appearing as the primary indexed condition, and to 0 interventions.

NCT00730678 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00730678 about?

NCT00730678 is a clinical study titled "Pharmacogenetic Determinants Of Treatment Response In Children". To investigate whether genetic polymorphisms in genes encoding proteins involved in the metabolism or effects of drugs or environmental agents influence the disposition or effects of these xenobiotic substrates. To investigate the nature of heritability and the genetic basis of pharmacogenetic trait...

What is the current status of trial NCT00730678?

This trial is currently recruiting. The enrollment target is 8,800 participants. The study started on 1998-08-17. Estimated completion is 2034-03.

What conditions does trial NCT00730678 study?

This clinical trial studies the following conditions: All Malignancies, Children Being Treated for Catastrophic Illness.

Who is sponsoring clinical trial NCT00730678?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00730678 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.